Climb Global Solutions (CLMB) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
5 Nov, 2025Executive summary
Net sales for Q3 2025 increased 35% year-over-year to $161.3 million, driven by organic growth and the DSS acquisition.
Achieved double-digit organic growth, supported by new and existing vendors, DSS acquisition, and deepened vendor partnerships.
Distribution segment drove growth, while Solutions segment saw a sales decline but higher gross profit.
Expanded AI capabilities in Europe with the launch of Climb AI Academy, attracting over 700 participants.
Maintained strong operational discipline and a robust balance sheet, positioning for continued growth and record results.
Financial highlights
Gross billings rose 8% year-over-year to $504.6 million; Distribution segment up 9%, Solutions segment down 5%.
Gross profit increased 6% to $25.7 million; gross profit margin on billings was 5.1% versus 5.2% last year.
Net income was $4.7 million ($1.02 per diluted share), down from $5.5 million ($1.19) year-over-year.
Adjusted net income was $6.0 million ($1.31 per share), down from $7.1 million ($1.55) last year.
Adjusted EBITDA was $10.9 million, slightly down from $11.1 million; effective margin was 42.3% versus 45.7%.
Outlook and guidance
Management expects a strong close to 2025 and another year of record performance, with continued focus on operational momentum and strategic initiatives.
Actively evaluating acquisition opportunities, especially in Europe, to enhance capabilities and expand market presence.
No signs of market slowdown; Q4 anticipated to be strong due to cyclical license renewals and budget cycles.
Working capital needs are anticipated to rise with business growth, but current liquidity is deemed sufficient for at least 12 months.
SG&A expenses as a percentage of gross billings expected to vary with sales volume and ongoing investments.
Latest events from Climb Global Solutions
- Record 2025 sales and income growth; dividend suspended to fund expansion and acquisitions.CLMB
Q4 202526 Feb 2026 - Q2 net income more than doubled, DSS acquisition boosts EdTech, and ERP drives efficiency.CLMB
Q2 20242 Feb 2026 - Q3 net sales rose 52% and net income more than doubled, fueled by organic and acquisition growth.CLMB
Q3 202417 Jan 2026 - Record 2024 results with 51% net income growth and strong security segment performance.CLMB
Q4 202426 Dec 2025 - Q1 2025 net sales up 49%, net income up 35%, and adjusted EBITDA at $7.6 million.CLMB
Q1 202524 Dec 2025 - Virtual meeting to elect directors, approve pay, set say-on-pay frequency, and ratify auditor.CLMB
Proxy Filing2 Dec 2025 - Q2 2025 net sales and income rose over 70%, led by organic growth and DSS acquisition.CLMB
Q2 202516 Nov 2025 - Q1 2025 gross billings surged 34% as focus on emerging tech and acquisitions drove strong growth.CLMB
Investor Presentation25 Jun 2025